220 related articles for article (PubMed ID: 31101826)
1. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ
Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome.
Kazakov DV; Grossmann P; Spagnolo DV; Vanecek T; Vazmitel M; Kacerovska D; Zelger B; Calonje E; Michal M
Am J Dermatopathol; 2010 May; 32(3):215-221. PubMed ID: 20075707
[TBL] [Abstract][Full Text] [Related]
3. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis.
Bell AH; Prieto VG; Ferrarotto R; Goepfert RP; Myers JN; Weber R; Bell D
Ann Diagn Pathol; 2019 Aug; 41():14-23. PubMed ID: 31128548
[TBL] [Abstract][Full Text] [Related]
4. CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinoma.
Williams EA; Montesion M; Sharaf R; Corines J; Patel PJ; Gillespie BJ; Pavlick DC; Sokol ES; Alexander BM; Williams KJ; Elvin JA; Ross JS; Ramkissoon SH; Hemmerich AC; Tse JY; Mochel MC
Mod Pathol; 2020 Dec; 33(12):2614-2625. PubMed ID: 32461623
[TBL] [Abstract][Full Text] [Related]
5. Spiradenoma and cylindroma originate from the hair follicle bulge and not from the eccrine sweat gland: an immunohistochemical study with CD200 and other stem cell markers.
Sellheyer K
J Cutan Pathol; 2015 Feb; 42(2):90-101. PubMed ID: 25354097
[TBL] [Abstract][Full Text] [Related]
6. Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression.
Rajan N; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
J Pathol; 2011 Jul; 224(3):309-21. PubMed ID: 21598248
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.
Davies HR; Hodgson K; Schwalbe E; Coxhead J; Sinclair N; Zou X; Cockell S; Husain A; Nik-Zainal S; Rajan N
Nat Commun; 2019 Oct; 10(1):4717. PubMed ID: 31624251
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.
Rajan N; Elliott R; Clewes O; Mackay A; Reis-Filho JS; Burn J; Langtry J; Sieber-Blum M; Lord CJ; Ashworth A
Oncogene; 2011 Oct; 30(41):4243-60. PubMed ID: 21552290
[TBL] [Abstract][Full Text] [Related]
9. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
10. [Spiradenoma, cutaneous cylindroma and familial multiple trichoepithelioma].
Magnin PH; Duhm G; Casas JG
Med Cutan Ibero Lat Am; 1977; 5(3):179-87. PubMed ID: 211357
[TBL] [Abstract][Full Text] [Related]
11. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
[TBL] [Abstract][Full Text] [Related]
12. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome.
Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M
Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280
[TBL] [Abstract][Full Text] [Related]
13. CYLD mutation characterizes a subset of HPV-positive head and neck squamous cell carcinomas with distinctive genomics and frequent cylindroma-like histologic features.
Williams EA; Montesion M; Alexander BM; Ramkissoon SH; Elvin JA; Ross JS; Williams KJ; Glomski K; Bledsoe JR; Tse JY; Mochel MC
Mod Pathol; 2021 Feb; 34(2):358-370. PubMed ID: 32892208
[TBL] [Abstract][Full Text] [Related]
14. Morphologically low-grade spiradenocarcinoma: a clinicopathologic study of 19 cases with emphasis on outcome and MYB expression.
van der Horst MP; Marusic Z; Hornick JL; Luzar B; Brenn T
Mod Pathol; 2015 Jul; 28(7):944-53. PubMed ID: 25857824
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous appendage tumors: familial cylindromatosis and associated tumors update.
Lian F; Cockerell CJ
Adv Dermatol; 2005; 21():217-34. PubMed ID: 16350444
[No Abstract] [Full Text] [Related]
16. Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.
Leonard N; Chaggar R; Jones C; Takahashi M; Nikitopoulou A; Lakhani SR
J Clin Pathol; 2001 Sep; 54(9):689-92. PubMed ID: 11533075
[TBL] [Abstract][Full Text] [Related]
17. Spiradenocylindrocarcinoma: a malignant hybrid tumor.
Carlsten JR; Lewis MD; Saddler K; Reilly P; Pan T; Gnepp DR; Robinson-Bostom L
J Cutan Pathol; 2005 Feb; 32(2):166-71. PubMed ID: 15606677
[TBL] [Abstract][Full Text] [Related]
18. Cylindroma of the breast with CYLD gene mutation: a case report and review of the literature.
Escher-Michlig V; Vlajnic T; Roma L; Marinucci M; Piscuoglio S; Matter M; Haug M; Weber WP; Muenst S
Mol Biol Rep; 2023 Aug; 50(8):7133-7139. PubMed ID: 37389703
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of p53 protein as an indicator of the malignant transformation in spiradenoma.
Biernat W; Kordek R; Woźniak L
Histopathology; 1995 May; 26(5):439-43. PubMed ID: 7657312
[TBL] [Abstract][Full Text] [Related]
20. Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmission.
Arefi M; Wilson V; Muthiah S; Zwolinski S; Bajwa D; Brennan P; Blasdale K; Bourn D; Burn J; Santibanez-Koref M; Rajan N
J Am Acad Dermatol; 2019 Dec; 81(6):1300-1307. PubMed ID: 31085270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
